Aidapak Recalls Digoxin Tablets Due to Potential Label Mixup
Aidapak Services is recalling Digoxin tablets because they may have been mislabeled as other medications. The repacked drugs were distributed in four western states.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA classified this recall as Class II. According to the rubric, an FDA Class II recall with potential for adverse health consequences (such as receiving the wrong medication) corresponds to a severity score of 4 (Severe), particularly given the critical nature of the drugs involved.
Plain-English summary
Aidapak Services, LLC is recalling Digoxin, Tablet, 0.125 mg, because the medication may have been mislabeled as other drugs. The recall involves repacked drugs distributed in Arizona, California, Oregon, and Washington. The specific products affected include four distinct pedigree codes with expiration dates ranging from April 30, 2014, to June 13, 2014.
The source text indicates that the Digoxin tablets may have been mislabeled as Melatonin, Desmopressin Acetate, Propranolol HCl, or Liothyronine Sodium. This labeling error creates a risk that patients may receive the wrong medication. The FDA has classified this recall as Class II, indicating that use of or exposure to the product might cause temporary or medically reversible adverse health consequences.
Consumers and healthcare providers should check their inventory for Digoxin tablets with the specific pedigree codes listed in the recall notice. If the product is found, it should be returned to the distributor or the recalling firm, Aidapak Services, LLC. Patients should consult their healthcare provider if they have questions about their medication.
The recalled product
- Product
- DIGOXIN, Tablet, 0.125 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00115981101.
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Prescription Medication
- Affected units
- 400
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (10)
- DIGOXIN
- Tablet
- 0.125 mg has the following codes: Pedigree: AD22609_4
- EXP: 4/30/2014
- Pedigree: AD46426_22
- EXP: 5/15/2014
- Pedigree: AD62829_8
- EXP: 5/23/2014
- Pedigree: W003154
- EXP: 6/13/2014.
Distribution
Part of a larger recall action
This product is one of 265 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 265 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- SevereBetter Bakehouse Recalls Donutful Chocolate Dipped Vanilla Cake Donuts for Undeclared Milk
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- LowMindray ePM Series Patient Monitor Manuals Recalled for Alarm Clarification
FDA (Devices) · 2026-10-14
Similar recalls
- SevereFinasteride Tablets Recalled for Potential Mislabeling as Other Medications
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Melatonin Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Pyridoxine HCL Tablets Due to Labeling Mixup
FDA (Drugs) · 2014-01-22
- SevereFDA Recalls Mislabeled HydrALAZINE Tablets Due to Label Mixup
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Colchicine Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-22
- SevereFDA Recalls FIDAXOMICIN Tablets Due to Potential Labeling Error
FDA (Drugs) · 2014-01-22